@article{TLCR5090,
author = {Ursula Nestle and José Belderbos},
title = {Rebuttal from Dr Nestle and Dr Belderbos},
journal = {Translational Lung Cancer Research},
volume = {4},
number = {5},
year = {2015},
keywords = {},
abstract = {We fully agree that in a case when a patient with a T2N0M0 NSCLC central in the hilum has no other curative treatment option and is not eligible for conventionally fractionated radiotherapy, we can discuss with him/her the potential risk of SBRT and the weakness of the available data and may offer this treatment when the patient agrees to bear this risk.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/5090}
}